What's Happening?
Evernorth has introduced a new specialty pharmacy program named Pharmacy Forward, which leverages artificial intelligence to improve patient care for those with complex health conditions. The program is initially being rolled out for Accredo Specialty
Pharmacy customers, with a planned investment of $100 million through 2028. The initiative aims to enhance care coordination and provide real-time personalized support, allowing care teams to focus more on clinical and patient care. The program is expected to improve medication adherence and reduce the time required for patients to receive prescriptions. Additionally, AI will facilitate proactive interventions in patient care, potentially increasing the use of personalized digital patient pathways by 25%.
Why It's Important?
The introduction of AI in pharmacy services represents a significant shift in healthcare delivery, potentially transforming how patients with complex conditions receive care. By streamlining processes and enhancing the efficiency of care teams, the program could lead to better health outcomes and increased patient satisfaction. The reduction in prescription processing time and improved medication adherence could also lower healthcare costs and improve the overall efficiency of the healthcare system. This initiative highlights the growing role of technology in healthcare and its potential to address challenges in patient care and service delivery.
What's Next?
Evernorth plans to expand the components of Pharmacy Forward to other pharmacy operations in the future, aiming to generate $400 million in value by the end of 2028. The program's success could prompt other healthcare providers to adopt similar AI-driven solutions, further integrating technology into patient care. Stakeholders, including healthcare providers and patients, may closely monitor the program's outcomes to assess its impact on healthcare delivery and patient satisfaction.
